These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

86 related articles for article (PubMed ID: 14978249)

  • 1. Random mutagenesis of the human adenosine A2B receptor followed by growth selection in yeast. Identification of constitutively active and gain of function mutations.
    Beukers MW; van Oppenraaij J; van der Hoorn PP; Blad CC; den Dulk H; Brouwer J; IJzerman AP
    Mol Pharmacol; 2004 Mar; 65(3):702-10. PubMed ID: 14978249
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-specific binding and activation of the human adenosine A(2B) receptor.
    Thimm D; Schiedel AC; Sherbiny FF; Hinz S; Hochheiser K; Bertarelli DC; Maass A; Müller CE
    Biochemistry; 2013 Jan; 52(4):726-40. PubMed ID: 23286920
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The four cysteine residues in the second extracellular loop of the human adenosine A2B receptor: role in ligand binding and receptor function.
    Schiedel AC; Hinz S; Thimm D; Sherbiny F; Borrmann T; Maass A; Müller CE
    Biochem Pharmacol; 2011 Aug; 82(4):389-99. PubMed ID: 21620804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Systematic identification of mutations that constitutively activate the angiotensin II type 1A receptor by screening a randomly mutated cDNA library with an original pharmacological bioassay.
    Parnot C; Bardin S; Miserey-Lenkei S; Guedin D; Corvol P; Clauser E
    Proc Natl Acad Sci U S A; 2000 Jun; 97(13):7615-20. PubMed ID: 10852946
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Scanning mutagenesis in a yeast system delineates the role of the NPxxY(x)(5,6)F motif and helix 8 of the adenosine A(2B) receptor in G protein coupling.
    Liu R; Nahon D; le Roy B; Lenselink EB; IJzerman AP
    Biochem Pharmacol; 2015 Jun; 95(4):290-300. PubMed ID: 25896847
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Domains for activation and inactivation in G protein-coupled receptors--a mutational analysis of constitutive activity of the adenosine A2B receptor.
    Peeters MC; Li Q; Elands R; van Westen GJ; Lenselink EB; Müller CE; IJzerman AP
    Biochem Pharmacol; 2014 Nov; 92(2):348-57. PubMed ID: 25179146
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The second extracellular loop of GPCRs determines subtype-selectivity and controls efficacy as evidenced by loop exchange study at A2 adenosine receptors.
    Seibt BF; Schiedel AC; Thimm D; Hinz S; Sherbiny FF; Müller CE
    Biochem Pharmacol; 2013 May; 85(9):1317-29. PubMed ID: 23500543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacological characterization of novel adenosine ligands in recombinant and native human A2B receptors.
    Varani K; Gessi S; Merighi S; Vincenzi F; Cattabriga E; Benini A; Klotz KN; Baraldi PG; Tabrizi MA; Lennan SM; Leung E; Borea PA
    Biochem Pharmacol; 2005 Nov; 70(11):1601-12. PubMed ID: 16219300
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of a potent inverse agonist at a constitutively active mutant of human P2Y12 receptor.
    Ding Z; Kim S; Kunapuli SP
    Mol Pharmacol; 2006 Jan; 69(1):338-45. PubMed ID: 16234484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Generation and characterization of highly constitutive active histamine H3 receptors.
    Takahashi K; Tokita S; Kotani H
    J Pharmacol Exp Ther; 2003 Oct; 307(1):213-8. PubMed ID: 12954820
    [TBL] [Abstract][Full Text] [Related]  

  • 11. GPCR structure and activation: an essential role for the first extracellular loop in activating the adenosine A2B receptor.
    Peeters MC; van Westen GJ; Guo D; Wisse LE; Müller CE; Beukers MW; Ijzerman AP
    FASEB J; 2011 Feb; 25(2):632-43. PubMed ID: 21030693
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Modulation of insulin release by adenosine A1 receptor agonists and antagonists in INS-1 cells: the possible contribution of 86Rb+ efflux and 45Ca2+ uptake.
    Töpfer M; Burbiel CE; Müller CE; Knittel J; Verspohl EJ
    Cell Biochem Funct; 2008 Dec; 26(8):833-43. PubMed ID: 18979526
    [TBL] [Abstract][Full Text] [Related]  

  • 13. New, non-adenosine, high-potency agonists for the human adenosine A2B receptor with an improved selectivity profile compared to the reference agonist N-ethylcarboxamidoadenosine.
    Beukers MW; Chang LC; von Frijtag Drabbe Künzel JK; Mulder-Krieger T; Spanjersberg RF; Brussee J; IJzerman AP
    J Med Chem; 2004 Jul; 47(15):3707-9. PubMed ID: 15239649
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence against adenosine analogues being agonists at the growth hormone secretagogue receptor.
    Johansson S; Fredholm BB; Hjort C; Morein T; Kull B; Hu PS
    Biochem Pharmacol; 2005 Aug; 70(4):598-605. PubMed ID: 15979585
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Asn229 in the third helix of VPAC1 receptor is essential for receptor activation but not for receptor phosphorylation and internalization: comparison with Asn216 in VPAC2 receptor.
    Nachtergael I; Gaspard N; Langlet C; Robberecht P; Langer I
    Cell Signal; 2006 Dec; 18(12):2121-30. PubMed ID: 16650965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adenosine is not a direct GHSR agonist--artificial cross-talk between GHSR and adenosine receptor pathways.
    Hermansson NO; Morgan DG; Drmota T; Larsson N
    Acta Physiol (Oxf); 2007 May; 190(1):77-86. PubMed ID: 17428235
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of cancer-related somatic mutations in the adenosine A
    Wang X; Jespers W; Bongers BJ; Habben Jansen MCC; Stangenberger CM; Dilweg MA; Gutiérrez-de-Terán H; IJzerman AP; Heitman LH; van Westen GJP
    Eur J Pharmacol; 2020 Aug; 880():173126. PubMed ID: 32348778
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Synthesis, biological evaluation, and molecular modeling of ribose-modified adenosine analogues as adenosine receptor agonists.
    Cappellacci L; Franchetti P; Pasqualini M; Petrelli R; Vita P; Lavecchia A; Novellino E; Costa B; Martini C; Klotz KN; Grifantini M
    J Med Chem; 2005 Mar; 48(5):1550-62. PubMed ID: 15743197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Agonist binding and activation of the rat beta(1)-adrenergic receptor: role of Trp(134(3.28)), Ser(190(4.57)) and Tyr(356(7.43)).
    Rezmann-Vitti LA; Louis SN; Nero TL; Jackman GP; Iakovidis D; Machida CA; Louis WJ
    Biochem Pharmacol; 2004 Aug; 68(4):675-88. PubMed ID: 15276075
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Regulation of A2B adenosine receptor functioning by tumour necrosis factor a in human astroglial cells.
    Trincavelli ML; Marroni M; Tuscano D; Ceruti S; Mazzola A; Mitro N; Abbracchio MP; Martini C
    J Neurochem; 2004 Dec; 91(5):1180-90. PubMed ID: 15569261
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.